Business

Holding steady: Foreclosures remain low while serious delinquencies continue to build up, CoreLogic reports

The U.S. 150-day delinquency rate reached its highest level since at least January 1999 Forbearance provisions have helped foreclosure rates maintain historic lows IRVINE, Calif.–(BUSINESS WIRE)–#Foreclosure–CoreLogic® (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today released its monthly

Business, Health Care

KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) demonstrated statistically significant improvement in Progression-Free Survival (PFS), Overall Survival (OS) and Objective Response Rate (ORR) versus Sunitinib as first-line treatment for patients…

LENVIMA Plus Everolimus Also Showed Statistically Significant Improvement in PFS and ORR Endpoints Versus Sunitinib Results of Investigational Phase 3 KEYNOTE-581/CLEAR Trial (Study 307) to be Presented at Upcoming Medical Meeting KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK): KEYTRUDA®